Semi-Annual Diagnostic Coverage & Reimbursement Conference
XiFin is proud to be a Platinum Sponsor of the 2025 Semi-Annual Diagnostic Coverage & Reimbursement Conference in San Diego, California. This intimate, discussion-driven conference offers the perfect opportunity to engage with public and private payors, learn from peer-led case studies, and foster meaningful connections with industry leaders.
Explore how XiFin’s innovative expertise and solutions can help organizations increase market access, navigate policy challenges, and maximize reimbursement.
Featured Sessions
Navigating the Clinical and Financial Complexities of MRD Testing
February 4, 2025 | 10:15 AM
Clarisa Blattner
Sr. Director, Revenue and Payor Optimization,
XiFin, Inc.
Minimal Residual Disease (MRD) testing plays a vital role in personalized oncology, enabling tailored treatment strategies and improved patient outcomes. However, the complexities of billing, reimbursement, and operational challenges can hinder its adoption and financial sustainability. This session will explore the clinical significance of MRD testing, strategies to overcome reimbursement barriers, and innovative approaches to optimize financial outcomes. Attendees will gain actionable insights to navigate coding challenges, inconsistent payor policies, and serial testing complexities while leveraging technology and partnerships to streamline processes and enhance efficiency.
Panel Discussion: Outreach to Commercial Payor Organizations to Adopt State Biomarker Laws
February 5, 2025 | 8:30 AM
Clarisa Blattner
Sr. Director, Revenue and Payor Optimization,
XiFin, Inc.
- Uncertainty in legislation leading to pushback from payors
- Insights from states where biomarker laws are in effect
- Communication & advocacy strategies to further adoption
- Ramifications of overruling commercial coverage decision-makers
